Skip to main navigation Skip to search Skip to main content

Study, Double-Blinded for the Immunogenicity and Consistency Evaluation of 3 Hib-MenCY-TT Vaccine Lots and Single-Blinded and Controlled for the Evaluation of Safety and Immunogenicity of GSK Biologicals' Haemophilus Influenzae Type b

Project: Research

Project Details

StatusFinished
Effective start/end date07/18/0612/31/09

Funding

  • GlaxoSmithKline: $16,263.78